Attorney and Former Grand Rapids Bar Assoc President Walter B. Freihofer Passed Away May 26, 2012

Courtesy of the Grand Rapids Bar Association

We were deeply saddened to learn that attorney and former Grand Rapids Bar Association president Walter B. Freihofer passed away on Saturday, May 26, 2012. He was 92.

Funeral service will be held on Saturday, June 9 at 11 a.m. at St. Mark’s Episcopal Church (134 North Division Avenue) in Grand Rapids. There will be no funeral home visitation.

Only 35 Days Left to Avoid Medicare eRx Penalties in 2013

Originally Posted by MSMS, May 25th

We hate to say it, but the time for “I’ll deal with this later” is officially over.

There are only 36 days left for physicians to become successful electronic prescribers (or qualify for an exemption) for the purpose of avoiding the Medicare Part B payment adjustment of 1.5% in 2013.

Physicians who take one of the following steps by June 30, can avoid this scheduled reduction to their Medicare Part B payments:

• Report via claims code G8644 at least one if he/she does not have prescribing privileges.
• Report via claims either G8642 or G8643 if he/she practices in a rural area without sufficient high speed internet access or practices in an area without sufficient available pharmacies for electronic prescribing, respectively.
• Report via claims at least 10 separate electronic prescribing events.
• File for one of the permitted hardships hereContinue reading

Miller Johnson law firm to relocate into the business suites of the Radisson Plaza on June 22nd

The Miller Johnson law firm will look to redefine its presence in Kalamazoo as it relocates in late June to the second level of the Radisson Plaza Hotel & Suites.

New EECP Medical Director at Borgess

New medical director appointed for Cardiopulmonary Rehabilitation and Enhanced External Counterpulsation.

Daniel Goldberger, MD, is the new medical director of Cardiopulmonary Rehabilitation and the Enhanced External Counterpulsation Program (EECP) at Borgess Health & Fitness Center.

As medical director, Dr. Goldberger will coordinate care of cardiac patients with their referring physician during their treatment time. He also is a physician with ProMed Family Practice in Portage, Mich. In addition, Dr. Goldberger has served as medical director with Borgess VNA Home Care and Borgess Visiting Nurse & Hospice since 2009, and also is chairman of the Borgess Visiting Nurse & Hospice Medical Advisory Board.

Prior to joining Borgess in 1992, Dr. Goldberger was an attending physician with Meadville
Medical Center in Meadville, Penn., and was a private practice physician in Cochranton, Penn. He also served as attending physician with Shawano Community Hospital in Shawano, Wis., and was a physician with the Menominee Tribal Clinic in Keshena, Wis.

Dr. Goldberg received a bachelor of science degree the University of Michigan, and earned his MD degree from Medical College of Ohio at Toledo. He was a pediatric intern with Graduate Medical Education Inc. in Lansing, Mich., and also completed a residency in family practice at St. Lawrence Hospital in Lansing, part of the Michigan State University program.

For information on Cardiopulmonary Rehabilitation and the Enhanced External Counterpulsation Program (EECP) or to schedule an appointment, call (269) 552.2200 or visit http://www.borgess.com.


Friends of Borgess Nursing Dinner Pays Tribute to Nursing Excellence

The Sixth-Annual Friends of Borgess Nursing Endowment Fund Awards Dinner honored the nursing excellence of today and tomorrow, including recognizing James Wierman, DO, FACP, with the prestigious Lamplighter Award.

Continue reading

$2M Gift Enhances Surgical Procedures at Borgess

Donation to Foundation spurs latest in robotic technology -

A $2 million gift from a group of anonymous donors to the Borgess
Foundation is strengthening minimally invasive surgical capabilities throughout Borgess Health. Continue reading

The Michigan Osteopathic Association (MOA), installed Edward J. Canfield, D.O. as its 114th president

The Michigan Osteopathic Association (MOA), represents more than 8,000 osteopathic physicians and students, installed Edward J. Canfield, D.O. as its 114th president during its annual House of Delegates meeting in Dearborn on May 16, 2012.  Continue reading

Keystone Pharmacy Approved for Reaccreditation by the Pharmacy Compounding Accreditation Board

Keystone Pharmacy is proud to announce that it has been approved for reaccreditation by the Pharmacy Compounding Accreditation Board, or PCAB, for sterile and non-sterile compounding through Feb. 1, 2015.

Keystone Pharmacy is one of only five pharmacies in Michigan that has received this accreditation and is the first to go through reaccreditation.  It was also among the original 50 pharmacies in the nation to receive the accreditation; today there are approximately 140 pharmacies that are PCAB accredited.

PCAB was created by eight of the leading organizations in the pharmacy profession for the purpose of recognizing those compounding pharmacies that have demonstrated their outstanding commitment to quality.  Accreditation means that the pharmacy ranks among the best in the nation for compliance with quality standards.

“We are exceptionally pleased to receive re-accreditation from the PCAB,” said Dave Miller, chief formulation scientist and co-owner.  “Demand for compounded medications continues to increase and quality remains of the utmost importance.  We are committed to providing the highest quality compounding services to our patients and are proud to be acknowledged for our efforts once again.”

Hospice Of Michigan Reaccredited by Community Health Accreditation Program

Community Health Accreditation Program, Inc. announced that Hospice of Michigan has been reaccredited under the CHAP Standards of Excellence through December 2014.

Continue reading

U-M News: Large-scale study finds treatment standard for rare cancer

Initial results from a first-of-its-kind international consortium of adrenal cancer researchers published in the New England Journal of Medicine suggest there might be a treatment standard for patients with this extremely rare and deadly disease.

The study, which was conducted at 40 adrenal cancer specialty centers across 12 countries, randomly assigned 304 patients with advanced adrenal cancer to undergo one of the two most successful combination chemotherapy treatments. One treatment combined the chemotherapy drugs etoposide, doxorubicin and cisplatin (EDP) with mitotane, and another combined streptozocin with mitotane.

Researchers found that the EDP plus mitotane treatment staved off progression of the disease longer than the other option. Neither regimen improved how long patients lived.

The consortium – which grew out of an international adrenal cancer symposium at the University of Michigan Health System in 2003 – is the first effort to compare treatment regimens in patients with advanced adrenal cancer. About 600 Americans a year are diagnosed with adrenal cancer and almost all will die within five years of diagnosis.

To read the full story please visit: http://www.uofmhealth.org/news/adrenal-cancer-0516